Welcome to the BioSense 2.0 Workshop CSTE Annual Conference Sunday June 3, :15pm 5:15pm

Transcription

1 Welcome to the BioSense 2.0 Workshop CSTE Annual Conference Sunday June 3, :15pm 5:15pm 1:15pm Welcome and Introduction Taha Kass-Hout, MD, MS 1:20pm 2:20pm State Presentations Illinois Tennessee Washington Q&A Craig Conover, MD, MPH Dr. Rendi Murphree, PhD, MS Yvonne Konnor, MPH Natasha Close, MPH 2:40pm BioSense Governance Update Richard Hopkins, MD, MSPH Bryant Karras, MD 2:55pm Q&A 3:00pm Break Refreshments provided 3:25pm CSTE Update Beth Dunbar, MPH 3:45pm Breakout Discussion Charlie Ishikawa, MSPH Beth Dunbar, MPH 5:00pm Closing and Evaluation Beth Dunbar, MPH Please sit with your regional colleagues! See table assignments on Page 2 of your packet.

2 Logistics Please sign in Restrooms Think about your jurisdictions BioSense 2.0 plans and needs - Exercise - Evaluation Questions? - Write on sticky note - Post to General Questions board

3 BioSense 2.0 Workshop CSTE Annual Conference Sunday June 3, :15pm 5:15pm 1:15pm Welcome and Introduction Taha Kass-Hout, MD, MS 1:20pm State Presentations 2:20pm 2:40pm 2:55pm Illinois Tennessee Washington Q&A BioSense Governance Update Q&A Craig Conover, MD, MPH Dr. Rendi Murphree, PhD, MS Yvonne Konnor, MPH Natasha Close, MPH Richard Hopkins, MD, MSPH Bryant Karras, MD 3:00pm Break Refreshments provided 3:25pm CSTE Update Beth Dunbar, MPH 3:45pm Breakout Discussion Charlie Ishikawa, MSPH Beth Dunbar, MPH 5:00pm Closing and Evaluation Beth Dunbar, MPH

4 CSTE BioSense 2.0 Update Beth Dunbar, MPH CSTE Annual Conference BioSense 2.0 Workshop June 3, 2012

5 Agenda CSTE s role in BioSense 2.0 The Current Landscape What s next?

6 CSTE s Role in BioSense 2.0 Support and participate in the BioSense 2.0 Governance Group Engage and inform CSTE Members Help states, territories, and large local health departments join the new environment

7 CSTE s Role Support & participate in the BioSense 2.0 Governance Group Interim Governance 2 CSTE Reps and 2 CSTE Staff participated Established Governance Charter Transitional Governance CSTE Representative: Jim Collins of Michigan Determine 3 State Reps with ASTHO Permanent Governance Electrons triggered when 25 DUA signed

8 CSTE s Role Engage and inform members Jun 2011: Initiated BioSense activities Fall 2011: Launched series of webinars Began contacting state, territorial, and large local health departments Winter and Spring: continued outreach and linking jurisdictions with BioSense Team

9 CSTE s Role Help jurisdictions join What s the current BioSense 2.0 landscape?

10 States with BioSense 1.0 DUA DC - 6 states signed DUA

11 Current BioSense 2.0 DUA Status * NYC DC LA - 26 states & 2 cities reviewing DUA - 13 states signed DUA *as of 05/29/2012

12 CSTE s Role Help jurisdictions join What s the current BioSense 2.0 landscape? Majority of states are formally considering joining BioSense states with spectrum syndromic surveillance expertise exploring system

13 CSTE s Role Help jurisdictions join Resources for the following topics: BioSense Data Visualizer: one-on-one demo here CDC s BioSense FOA: Taha & Sharon here and happy to answer questions Syndromic surveillance 101 & data uses BioSense Data Elements, Transport, Analysis, and Security Typo! BioSense Data Use Agreement

14 What s next? CSTE formal outreach activities wrap-up in August Continue BioSense 2.0 discussions on Surveillance Practice and Implementation Subcommittee How can the CSTE National Office support?

15 The BioSense Team Introductions Association of State Health Officials Jim Kirkwood Scott Gordon National Association of County and City Health Officials Mike Coletta Vanessa Holley International Society for Disease Surveillance Charlie Ishikawa Julia Gunn Centers for Disease Control and Prevention Taha Kass-Hout Kate Spears

16 ISDS Syndromic Surveillance Community Call Thursday, June 14 from 12-1pm EDT Attendee-driven agenda, suggest topics! Register by: Amanda Schulte note on today s Workshop Evaluation form

17 Thank you! Beth Dunbar